Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.
A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.
Read More
The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical…
Read More
This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps…
Read More
Prospective study conducted by the Diabetes Prevention Program Research Group, looking at reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Read More
An open-label randomized study analyzing the effect of two doses of growth hormone (GH) on final height and height velocity during the first 2 years of treatment of children with idiopathic short stature.
Read More